株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

消化酵素の世界市場 - 成長、動向、予測

Digestive Enzymes Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 708648
出版日 ページ情報 英文 111 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.53円で換算しております。
Back to Top
消化酵素の世界市場 - 成長、動向、予測 Digestive Enzymes Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年03月01日 ページ情報: 英文 111 Pages
概要

当レポートでは、消化酵素の世界市場を調査し、市場の概要、タイプ、用途、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入の脅威
    • 代替製品とサービスの脅威
    • 業界内での競争

第6章 市場ダイナミクス

  • 成長要因
  • 阻害要因
  • 市場機会
  • 課題

第7章 市場セグメンテーション

  • 酵素タイプ別
    • カルボヒドラーゼ
    • プロテアーゼ
    • リパーゼ
    • その他
  • 用途別
    • 幼児栄養
    • 医療栄養
    • スポーツ栄養
    • その他
  • 原産別
    • 動物
    • 真菌
    • 微生物
    • 植物
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第8章 企業プロファイル

  • AbbVie Inc.
  • Allergan PLC
  • Amano Enzyme Inc.
  • Amway Corporation
  • Biotics Research Corporation
  • Country Life LLC
  • Garden of Life Inc.
  • National Enzyme Company Inc.
  • Johnson & Johnson Inc.

第9章 市場の将来展望

目次
Product Code: 64282

Market Overview

The digestive enzymes market is expected to register a CAGR of 7.2% over the forecast period. Factors, such as the rising geriatric population, the rising prevalence of gastrointestinal disorders, increasing awareness about GI health, and focus on preventive health management are contributing to the market growth. However, the general public's perception of probiotic and prebiotic products as alternatives to digestive enzymes and stringent regulatory policies could adversely affect the growth of the market.

The global population is aging rapidly, owing to reduced birth rates and increasing life expectancy. The demographic trend toward an aging population represents a growing need for the management of disorders, such as GI tract obstructions. The number of older people is estimated to increase by nearly 60% in the next 15 years, and by 2030, the total number of people aged above 65 is expected to be more than a billion, i.e., the geriatric population would represent 12% of the global population. By 2050, this number is expected to cross 1.6 billion, or 16.7% of the total population. The secretion of digestive enzymes usually decreases with age, which contributes to high levels of gastric discomfort, lower digestion rates, reduced food consumption, and/or a variety of other GI disorders. Therefore, with the increasing geriatric population, the market for digestive enzymes is expected to increase over the forecast period.

The digestive enzymes market is expected to register a CAGR of 7.2% over the forecast period. Factors, such as the rising geriatric population, the rising prevalence of gastrointestinal disorders, increasing awareness about GI health, and focus on preventive health management are contributing to the market growth. However, the general public's perception of probiotic and prebiotic products as alternatives to digestive enzymes and stringent regulatory policies could adversely affect the growth of the market.

The global population is aging rapidly, owing to reduced birth rates and increasing life expectancy. The demographic trend toward an aging population represents a growing need for the management of disorders, such as GI tract obstructions. The number of older people is estimated to increase by nearly 60% in the next 15 years, and by 2030, the total number of people aged above 65 is expected to be more than a billion, i.e., the geriatric population would represent 12% of the global population. By 2050, this number is expected to cross 1.6 billion, or 16.7% of the total population. The secretion of digestive enzymes usually decreases with age, which contributes to high levels of gastric discomfort, lower digestion rates, reduced food consumption, and/or a variety of other GI disorders. Therefore, with the increasing geriatric population, the market for digestive enzymes is expected to increase over the forecast period.

Scope of the Report

Digestive enzymes represent a group of enzymes secreted by the digestive organs for breaking down complex macromolecules into their constituents, in order to facilitate their absorption by the body. Several digestive enzymes are commercially available as dietary supplements and for the management of digestive disorders.

Key Market Trends

Animal Origin Segment Captured the Largest Market Share in Origin

The animal origin sub-segment holds the largest market share in the origin segment and is expected to follow the same trend over the forecast period.

The major factors that are responsible for the growth of the segment include the efficiency of these animal-derived enzymes in various diseases or conditions, such as pancreatitis, exocrine pancreatic insufficiency, and pancreatic cancer. However, ethical issues associated with animal origin products in some consumers are expected to hamper the segment growth. In addition to this, the allergies and sensitivity of consumers to these animal origin products are also expected to hamper their market growth.

The microbial enzyme, on the other hand, is expected to witness the fastest growth rate over the forecast period. This growth rate of the microbial origin products can be attributed to factors, such as low production cost and high enzymatic activity.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America emerged as the largest regional market, in terms of revenue. The increasing prevalence of chronic gastrointestinal diseases, rapidly aging population, growing demand for preventive medicine, and the presence of major market players are primary factors contributing to the large market size. Apart from the high prevalence of GI disorders, the changing lifestyle, unhealthy eating habits, and high disposable income are contributing to the high growth rates. On the other hand, Asia-Pacific is expected to exhibit the fastest growth rate over the forecast period.

Competitive Landscape

There is the presence of major market players, such as Allergan PLC, Johnson & Johnson Inc., Amway Corporation, AbbVie Inc., and Biotics Research Corporation, among others. The increasing innovation and rise in investment for various public and private organizations are expected to intensify the industry rivalry across the globe.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population
    • 4.2.2 Rising Prevalence of Gastrointestinal Disorders
    • 4.2.3 Increasing Awareness about GI Health and Focus on Preventive Health Management
  • 4.3 Market Restraints
    • 4.3.1 Perception of Probiotic and Prebiotic Products as Alternatives to Digestive Enzymes
    • 4.3.2 Stringent Regulatory Policies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Enzyme Type
    • 5.1.1 Carbohydrates
    • 5.1.2 Protease
    • 5.1.3 Lipase
    • 5.1.4 Other Enzyme Types
  • 5.2 By Application
    • 5.2.1 Indigestion
    • 5.2.2 Chronic Pancreatitis
    • 5.2.3 Irritable Bowel Syndrome
    • 5.2.4 Other Applications
  • 5.3 By Origin
    • 5.3.1 Animal
    • 5.3.2 Fungi
    • 5.3.3 Microbial
    • 5.3.4 Plant
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AbbVie Inc.
    • 6.1.2 Allergan PLC
    • 6.1.3 Amano Enzyme Inc.
    • 6.1.4 Amway Corporation
    • 6.1.5 Biotics Research Corporation
    • 6.1.6 Country Life LLC
    • 6.1.7 Garden of Life Inc.
    • 6.1.8 National Enzyme Company Inc.
    • 6.1.9 Johnson & Johnson Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top